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Agingsmic material and organelles to lysosomes for degradation. The formation of
autophagosomes is controlled by a speciﬁc set of autophagy genes called atg genes. The magnitude of
autophagosome formation is tightly regulated by intracellular and extracellular amino acid concentrations
and ATP levels via signaling pathways that include the nutrient sensing kinase TOR. Autophagy functions as a
stress response that is upregulated by starvation, oxidative stress, or other harmful conditions. Remarkably,
autophagy has been shown to possess important housekeeping and quality control functions that contribute
to health and longevity. Autophagy plays a role in innate and adaptive immunity, programmed cell death, as
well as prevention of cancer, neurodegeneration and aging. In addition, impaired autophagic degradation
contributes to the pathogenesis of several human diseases including lysosomal storage disorders and muscle
diseases.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Autophagy is an evolutionarily conserved and strictly regulated
lysosomal pathway that degrades cytoplasmic material and orga-
nelles [1,2]. Autophagy is activated during stress conditions such as
amino acid starvation, unfolded protein response or viral infection.
Depending on the delivery route of the cytoplasmic material to the
lysosomal lumen, three different autophagic routes are known: 1)
macroautophagy, or simply autophagy, 2) microautophagy, and 3)
chaperone-mediated autophagy. In macroautophagy, a portion of
cytoplasm to be degraded is ﬁrst wrapped inside a specialized
organelle, the autophagosome, which then fuses with lysosomal
vesicles and delivers the engulfed cytoplasm for degradation (Fig. 1).
In microautophagy, the lysosomal membrane itself sequesters a
portion of cytoplasm by a process that resembles pinching off of
phagosomes or pinosomes from the plasma membrane [3]. In
chaperone-mediated autophagy, proteins possessing a speciﬁclum; HOPS, homotypic vacuole
embrane protein; MHC, major
NSF, N-ethylmaleimide-sensi-
I, phosphatidyl inositol; SNAP,




ll rights reserved.sequence signal are transported from the cytoplasm, through the
lysosomal membrane, to the lysosomal lumen [4].
After induction by a stress signal such as starvation, the ﬁrst
step in (macro)autophagy is the formation of an autophagosome
(Fig. 1). A ﬂat membrane cistern elongates and wraps itself around
a portion of cytoplasm or a speciﬁc cargo, forming a double-
membrane bound autophagosome. This membrane cistern is called
the phagophore, or isolation membrane. Autophagosomes next
receive lysosomal constituents, such as lysosomal membrane
proteins and proton pumps, by fusion with late endosomes or
multivesicular bodies (MVBs). Finally, autophagosomes fuse with
lysosomes [5–11] (Fig. 1). After fusion with endosomes or
lysosomes, autophagosomes are called amphisomes or autolyso-
somes, respectively. Both the cytoplasm and the inner limiting
membrane around it are degraded by lysosomal hydrolases, and the
degradation products are transported back to cytoplasm where they
can be reused for biosynthesis or energy production. After all
material has been degraded in autolysosomes, they are assumed to
become lysosomes that are able to undergo another fusion with
endosomes or autophagosomes. Another possibility is that, if the
degradation of the cargo is not complete, the autolysosome
becomes a residual body containing indigestible material and
lipofuscin pigment. Morphology of a typical autophagosome and a
lysosome is depicted in Fig. 2.
The purpose of this review is to give a general overview of the
cellular roles of autophagy and highlight the relevance of this pathway
Fig. 1. Schematic presentation of autophagosome formation and maturation by fusion
with endosomes and lysosomes. The arrowhead on the left illustrates the induction
signal that initiates the process.
Fig. 2. Transmission electron micrograph showing an autophagosome (AP) and a
lysosome (L) in amouse ﬁbroblast. The cells were fed with protein-coated gold particles
for 2 h to ﬁll the endosomal and lysosomal compartments (black dots inside the
lysosome). The autophagosome is located next to microtubules (arrows).
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reference list for those readers whowish to read more about a speciﬁc
aspect of autophagy.
2. Autophagosome formation and maturation into autolysosomes
The origin of the membrane cisterns that form new autophago-
somes remains unresolved [12]. Studies in yeast have revealed that
autophagosomes originate from a unique compartment called the
preautophagosomal structure or phagophore assembly site (PAS) [13–
15]. It is not clear at present whether the PAS is a pre-existing
compartment or a short-lived intermediate during autophagosome
formation. The PAS can be detected by ﬂuorescence microscopy as a
spot next to the vacuolewhere the autophagy proteins are located, but
so far the ultrastructure of this compartment has not been character-
ized. Because the autophagic pathway is well conserved from yeast to
mammals, it is possible that a similar or equivalent unique compart-
ment or intermediate also exists inmammalian cells. The phagophore/
isolation membrane is the earliest morphologically detectable autop-
hagy compartment in mammalian cells [16]. The phagophore is likely
to be a compartment downstream of the putative PAS.
Several studies suggest that in yeast, membrane transport out of
the endoplasmic reticulum (ER) contributes to autophagosome
formation. COPII-coated vesicles transport material from the ER to
the Golgi complex. Yeast mutants defective in a subset of COPII
components are unable to form autophagosomes [17,18]. However, it
is possible that the role of the essential COPII proteins is indirect, since
not all COPII components are essential for autophagosome formation.
Transport protein particle (TRAPP) is a complex of ten subunits that is
essential for tethering of ER-derived transport vesicles to Golgi
membranes. Trs85, a component of the TRAPP complexes, was
reported to be required for macroautophagy and autophagy of
peroxisomes [19], and for the selective cytoplasm to vacuole targeting
(Cvt) in yeast [19,20]. These results, together with other studies on
yeast [21], also suggest a role for the secretory pathway in
autophagosome formation. Unexpectedly, conventional membrane
fusion machinery, including N-ethylmaleimide-sensitive fusion pro-
tein (NSF), soluble NSF attachment protein SNAP, and SNAP receptors,
are not needed for autophagosome formation in yeast [18,22]. This
suggests that unconventional membrane trafﬁc pathways are used
during autophagosome formation.
After their formation, autophagosomes undergo a stepwise
maturation process including fusion events with multivesicular
endosomes and lysosomes [1,23]. Fusion with endosomal compart-
ments depends on Vps4/SKD1 and Rab11 [24,25]. A recent study
shows that autophagosome–endosome fusion is enhanced by compo-
nents of the HOPS complex (homotypic fusion and protein sorting)
[26]. Further, several studies show that autophagosome maturation is
impaired if Hrs or subunits of the ESCRT III complex, proteins needed
for the biogenesis of multivesicular endosomes, are absent or non-functional [27–30]. Fusion with lysosomes is necessary for the
complete degradation of segregated cytoplasm. Intact microtubules,
the microtubule motor dynein, the small GTP-binding protein Rab7,
components of the HOPS complex, and the lysosomal membrane
protein LAMP-2 facilitate the fusion of autophagosomes with
lysosomes [26,31–36]. In addition, SNARE proteins were shown to
be necessary for the fusion of autophagosomes with the vacuole in
yeast [18,37].
3. Atg-proteins
Yeast genetics has immensely enlarged the knowledge of the
molecularmechanisms of autophagy [38]. About 30 autophagy-related
yeast genes are known [2,22,39,40]. All autophagy-related novel genes
are described by a common name, ATG [41]. Several mammalian
homologues of yeast ATG genes have been identiﬁed, and the
mechanisms of yeast autophagy are largely conserved in mammals.
Atg1 is a serine–threonine kinase that functions in the signaling
pathway activating autophagy [42–44]. Atg1 interacts with Atg13 in a
manner that is regulated by phosphorylation. During autophagy
induction, the phosphorylation of Atg13 is decreased, which increases
the assembly of Atg1-Atg13 complexes [42]. Themammalian homolog
of Atg1 is called ULK1 [43].
Atg6 functions either on the signaling pathway, or early during the
formation of autophagosomes. The mammalian homolog of Atg6 is
called Beclin 1. This protein has a central role in the regulation of
autophagy. Beclin 1 forms a complex with the class III phosphatidy-
linositol 3-kinase (PI3-kinase) Vps34 [45,46]. Vps34 is associated with
the serine/threonine kinase Vps15 [47]. In addition, UVRAG (UV
irradiation resistance-associated gene) associates with the Beclin 1-
Vps34 complex and enhances autophagy [48]. Further, a protein called
Ambra 1 binds to Beclin 1 and enhances Vps34 kinase activity and
autophagosome formation [49]. Further, Bif-1 (also known as Endo-
philin B1) interacts with Beclin 1 through UVRAG and functions as a
positive mediator of Vps34 activity [50]. Bif-1 localizes to autophago-
somes. Beclin 1 also binds the proto-oncogenic proteins Bcl-2 and Bcl-
XL. This binding decreases the PI3-kinase activity associated with
Beclin 1 and inhibits autophagosome formation [51,52]. The compo-
nents of the Beclin 1 complex are illustrated in Fig. 3.
Two novel protein conjugation systems are necessary for autop-
hagosome formation, the Atg12-Atg5 and the Atg8-phosphatidyl
ethanolamine systems [53]. The mechanisms of both conjugation
systems closely resemble ubiquitin ligation to proteins, with
Fig. 4. Two protein conjugation systems necessary for autophagosome formation. Atg12
is ligated to Atg5 in a process assisted by the enzymes Atg7 and Atg 10. Atg12–Atg5
conjugates form larger oligomers with Atg16. Atg8/LC3-I is ligated to the lipid
phosphatidyl ethanolamine (red wavy lines) in reactions assisted by Atg4, Atg7, and
Atg3. The role of Atg4 is to cleave the carboxyl terminus of LC3-I to expose a glycine
residue. Atg7 and Atg3 assist in the conjugation with the lipid. The lipid is thought to
anchor Atg8/LC3-II to membranes.
Fig. 3. The Beclin 1–Vps34 complex. The Vps15 subunit of Vps34 has a lipid tail that may
assist to anchor the complex to a membrane. The proteins on blue background enhance
Vps34 lipid kinase activity and autophagy. Beclin 1, UVRAG, Bif-1 and Ambra 1 are
tumor suppressors. The proto-oncogenes Bcl-2 and Bcl-XL inhibit the binding of Vps34
to Beclin 1 and inhibit autophagy.
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(Fig. 4). Atg12-Atg5 conjugate assists the formation, but is not present
in sealed, autophagosomes [16]. Atg8 (called LC3 in mammals) also
assists autophagosome formation, possibly by enhancing membrane
fusion [54]. Atg8/LC3 is also present in sealed autophagosomes [55].
Soluble LC3 is called LC3-I, and the lipidated, autophagosome-speciﬁc
form is called LC3-II.
4. Regulation of autophagy
Availability of nutrients, amino acids in particular, is an important
physiological regulator of macroautophagy [56–58]. Autophagy is
induced by amino acid starvation, and amino acids generated by
degradation of autophagocytosed proteins act as a feedback inhibitor
of autophagosome formation. Two amino acid sensors have been
proposed in autophagy signaling: the protein kinase Gcn2, which is
activated by uncharged transfer RNA molecules [59], and a putative
amino acid receptor located on the plasma membrane [60]. Gcn2
senses intracellular amino acid levels, while the putative plasma
membrane amino acid receptor senses extracellular amino acids. The
signals from Gcn2 to autophagy are mediated by a pathway including
the eukaryotic initiation factor eIF2α, which supports autophagy
when phosphorylated at Ser51 [59]. The putative amino acid receptor
at the plasmamembranewas proposed tomediate the signals from an
extracellular non-transportable leucine analogue to the autophagic
pathway [60], possibly via the target of rapamycin (TOR) kinase.
A recent study shows that amino acids regulate the binding of Bcl-
2 to Beclin 1 [61]. As described above, the binding of Bcl-2 to Beclin 1
inhibits autophagy by inhibiting the Beclin 1-associated PI3 kinase
activity [52]. Now, starvation was shown to induce the phosphoryla-
tion of Bcl-2, which inhibits the binding of Bcl-2 to Beclin 1 and leads
to autophagy activation [61]. Further, the study shows that c-Jun N-
terminal kinase 1 (JNK1) mediates this Bcl-2 phosphorylation [61].
Trimeric G proteins [62] and some proteins associated with them
[63] also regulate autophagosome formation. This signaling is
dependent on the activity of MAP kinases ERK1/2, which are turned
off in the presence of amino acids [64]. Thus, amino acid signaling and
control of autophagy by trimeric G proteins also seem to have a link
[62].
TOR protein kinases play a conserved role in nutrient sensing,
regulation of growth and proliferation, and control of a wide variety of
metabolic processes. TOR plays a crucial role in autophagy regulation
[65], which is in line with its role as a nutrient sensor. Active TOR
kinase inhibits autophagy, and inhibition of the kinase activity by
rapamycin activates autophagy [42,66]. TOR can also act as a sensor for
intracellular ATP. AMP-activated protein kinase mediates the ATP
sensing of TOR [67]. Thus ATP levels can control autophagy directly,
and/or via TOR signaling [68]. Free cytosolic calciumwas also reported
to control macroautophagy: a rise in cytosolic calcium inducesautophagy [69]. Several calcium mobilizing agents including vitamin
D3 and ATP were shown to inhibit TOR, suggesting free calcium
functions upstream of TOR in autophagy signaling. This signaling is
mediated by calcium/calmodulin-dependent kinase kinase-β and
AMP-activated protein kinase [69].
Phosphatidyl inositol 3-kinases (PI3-kinases) also regulate autop-
hagy. As discussed above, the activity of class III PI3-kinase Vps34 is
absolutely required for autophagosome formation [70,71]. Class I PI3-
kinases have an opposite effect on autophagy: the activation of these
kinases is inhibitory [71]. In line with this, PTEN, a phosphatase that
decreases the concentration of class I PI3 kinase product, enhances
autophagy [72]. Ras proteins function in signaling involved in cell
proliferation and their mutations can causemalignant transformation.
Ras was shown to participate in the negative control of starvation-
induced autophagy upstream of class I PI3 kinase [73–75].
The transcription factor FoxO3 regulates muscle atrophy. This
transcription factor was shown to be necessary and sufﬁcient for
autophagy induction in skeletalmuscle [76,77]. FoxO3wasalso shown to
function downstream of Akt/PKB, by increasing the expression of many
autophagy-related genes. The effect of FoxO3 on autophagy is not
prevented by rapamycin, indicating it is independent of TOR signaling.
Fig. 5 summarizesmostof the autophagy regulatory factors described
above. For more detailed discussion on the regulation of autophagy, the
reader is referred to specialized review [56–58,62,65,78,79].
5. Physiological functions of autophagy
5.1. Stress response and housekeeping function
The role of autophagy as a survival mechanism during short-term
amino acid starvation is well documented. Macroautophagy is
induced by starvation of serum and amino acids; autophagosomes
can be detected already after 15–30 min of starvation [55]. During
long-term starvation, chaperone-mediated autophagy increases and
Fig. 5. A simpliﬁed and hypothetical model on signaling pathways that regulate
macroautophagy. GTPase, trimeric GTP-binding protein, AMPK, AMP-activated protein
kinase; eIF2α, eukaryotic initiation factor 2α; ROS, reactive oxygen species.
667E.-L. Eskelinen, P. Saftig / Biochimica et Biophysica Acta 1793 (2009) 664–673macroautophagy decreases [80,81]. Yeast strains defective in autop-
hagy do not survive nitrogen starvation [38]. Knockout mice deﬁcient
in one of the central autophagy proteins, Atg5, show that autophagy is
indispensable for the energy metabolism immediately after birth [82].
Atg5 knockout mice die of starvation one day after birth.
In muscle and heart cells, autophagy seems to have a special
housekeeping role in the turnover of cytoplasmic constituents
including mitochondria. This is revealed bymyopathy and cardiomyo-
pathy in patients and mice possessing a defective autophagic
degradation due to deﬁciency of the lysosomal membrane protein
LAMP-2 [83–85]. LAMP-2 deﬁciency is described in detail later in this
review. The importance of autophagy for the heart muscle is
supported by a study showing that heart-speciﬁc loss of the
autophagy protein Atg5 causes cardiomyopathy inmice [86]. Evidence
has been published suggesting that damaged mitochondria might be
autophagocytosed selectively in a process termed mitophagy [87].
Mitochondria are the major source of reactive oxygen species in cells.
Interestingly, reactive oxygen species are necessary for the signal
transduction pathway initiating starvation-induced autophagy [88].
It was proposed long ago that autophagy has a role in growth
regulation, as suggested by decreased autophagy during growth of the
kidney after unilateral nephrectomy [89]. Inducible knockdown of the
autophagy protein Atg5 in cell culture shows that autophagy
negatively controls cell size [90]. Similar result was observed in Dro-
sophila fat body over-expressing the autophagy protein Atg1 [91].
Autophagy contributes to intracellular quality control and house-
keeping, especially in turnover of aggregate-prone proteins. Preven-
tion of autophagy by conditional knockout of atg7 leads to
accumulation of ubiquitinated protein aggregates in mouse tissues
[92]. Tissue-speciﬁc knockout of autophagy proteins in the central
nervous system causes accumulation of ubiquitin-positive protein
aggregates and neurodegeneration in mice [93,94]. Further, enhanced
autophagy reduces the toxicity of the Huntingtin protein aggregates
that accumulate in Huntington disease [95]. Autophagy may prevent
aggregate formation by degrading the proteins as monomers,
oligomers, or after aggregate formation [96]. It is not clear at present
whether aggregated proteins are segregated preferentially, or
whether they are removed via unspeciﬁc autophagic uptake of
cytoplasm. Two proteins have been proposed to function during the
uptake of protein aggregates: Alfy and p62 [97,98]. p62 binds to both
ubiquitin-conjugated aggregate-prone proteins and the autophago-
some protein LC3 [99], which suggests that it could selectively recruitautophagy machinery to the aggregates and enhance their autophagic
clearance.
In addition to removal of cytoplasmic aggregate-prone proteins,
autophagy also contributes to the quality control in the ER. Unfolded
protein response induces autophagy, and this induction is beneﬁcial
for cell survival [100–102].
Autophagic degradation is also needed for early embryonic
development. A recent study shows that autophagy-defective mouse
eggs fertilized with autophagy-defective sperm, failed to develop
beyond the four and eight cell stages [103]. The authors suggest that
autophagy may be needed in the preimplantation embryos for protein
recycling, production of amino acids for protein synthesis or
substrates for energy production, or for removal of obsolete maternal
factors.
5.2. Innate and adaptive immunity
Autophagy contributes to both innate and adaptive immunity
[104,105]. In some cases autophagy can protect cells against
intracellular pathogens. Induction of autophagy during Herpes simplex
virus infection, and localization of viral particles inside autophagic
vacuoles, were proposed to indicate that autophagy acts as a host-
defense mechanism in infected cells [59]. The Herpes virus virulence
protein, ICP34.5, inhibits autophagy, suggesting that the virus has
developed a way to prevent the autophagic defense of the host cell.
Autophagy may also help cells to defend against intracellular bacteria
[106]. Sequestration of intracellular Group A Streptococci in autopha-
gosome-like structures protects cells against the bacteria [107]. My-
cobacterium tuberculosis is normally able to survive inside
macrophages by preventing the fusion of phagosomes with lyso-
somes. Surprisingly, induction of autophagy bypasses the maturation
defect, leading to phagolysosome formation and bacterial killing [108].
Macroautophagy also contributes to antigen presentation. Major
histocompatibility complex (MHC) class II molecules present products
of lysosomal proteolysis to CD4(+) T cells. Extracellular antigen
uptake is considered to be the main source of MHC class II ligands.
However, it was demonstrated that in MHC class II-positive cells,
including dendritic cells, B cells, and epithelial cells, autophagosomes
continuously fuse with multivesicular MHC class II-loading compart-
ments [109]. This pathway is of functional relevance, because
targeting of the inﬂuenza matrix protein 1 to autophagosomes
enhances its MHC class II presentation to CD4(+) T cells. Thus it
seems that macroautophagy efﬁciently delivers cytosolic proteins for
MHC class II presentation and can improve helper T cell stimulation.
5.3. Cell death
Autophagy also seems to have roles in programmed cell death
[110,111]. Type II programmed cell death, or autophagic cell death, was
originally described in mammary carcinoma cells [112,113]. Autop-
hagy proteins were shown to be necessary for cell death under certain
conditions, such as in apoptosis-defective cells [114–116]. In this
scenario autophagy is needed for the execution of cell death. Under
other conditions, such as nutrient starvation, autophagy protects cells
against apoptosis by providing nutrients [117–119]. The regulation of
apoptosis and autophagy are linked via the antiapoptotic protein Bcl-
2. Bcl-2 inhibits Beclin 1-dependent autophagy by binding to Beclin 1
and preventing its association with Vps34 [52]. This anti-autophagy
function of Bcl-2 was proposed to help maintain autophagy at levels
that are compatible with cell survival, rather than cell death.
Lipids may also regulate autophagy and its outcome to the host
cell. Ceramide and sphingosine 1-phosphate, a metabolite of cer-
amide, both induce autophagy inmammalian cells [120]. The outcome
on cell survival is however different: ceramide promotes cell death,
while sphingosine 1-phosphate increases cell survival. Ceramide is
part of the signaling cascade initiated by chemotherapy, while
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starvation. Beclin 1 level and the autophagy response are stronger
during ceramide signaling [121].
Autophagy has functions in cell death during development [122].
atg genes are necessary for the clearance of apoptotic cells during
embryonic development in mice [123]. Autophagy contributes to
dead-cell clearance during programmed cell death by maintaining
cellular energy levels in the dying cells, thereby allowing the
generation of cell surface and secreted signals that then promote
engulfment of cell corpses by neighboring cells. Autophagy is also
indispensable for the execution of certain types of cell death during
development. The degradation of Drosophila salivary glands by type II
programmed cell death depends on autophagy [73].
5.4. Aging and longevity
Finally, autophagy also contributes to longevity [124]. Reduced
caloric intake increases longevity in several animal species. Increased
autophagic turnover of cytoplasmic constituents including mitochon-
dria was shown to contribute to the longer life in the dieting animals
[125]. Further evidence that autophagy contributes to longevity come
from Caenorhabditis elegans mutants possessing a defective insulin
receptor (daf2 mutant), which live longer than control worms. The
increased lifetime of these mutant worms depends on a functional
autophagic pathway [126]. Moreover, knockdown of autophagy gene
products including Atg7 and Atg12were shown to shorten the lifespan
of both wild type and daf2mutant C. elegans [127]. Further, promoting
basal levels of autophagy in the nervous system of adult Drosophila
enhances longevity of theﬂies [128]. Together these studies give strong
support for a role of autophagy in the prevention of aging.
Fig. 6 summarizes the physiological functions of autophagy
described above.
6. Autophagy and disease
6.1. Cancer
Impaired autophagy contributes to cancer development
[2,129,130]. Beclin 1 is monoallelically deleted in a large proportion
of human breast and ovarian cancers. Over-expression of Beclin 1 in a
breast cancer cell line increases autophagy and decreases the growth
and tumorigenicity of these cells [131]. Mice with heterozygous
deletion of Beclin 1 have less autophagy andmore tumors than control
mice [132,133]. Further, the other autophagy-promoting components
of the Beclin 1/Vps34 complex, UVRAG and Ambra 1 (Fig. 4), are also
tumor suppressors [48,49]. Moreover, knockout of Bif-1, also part of
the Beclin 1 complex, signiﬁcantly enhances the development ofFig. 6. A summary of the functions of autophagy in health and disease.spontaneous tumors in mice [50]. On the other hand, binding of the
proto-oncogenic proteins Bcl-2 or Bcl-XL to Beclin 1 inhibit autophagy
[51,52]. In addition to the Beclin 1 complex, other tumor suppressors
also enhance autophagy. PTEN is a phosphatase that decreases the
concentration of class I PI3 kinase product and enhances autophagy
[72]. PTEN is also a tumor suppressor [134]. Further, the activities of
Ras and class I PI3-kinases inhibit autophagy and promote cell growth.
Ras is mutated and class I PI3 kinases are upregulated in many cancers
[135,136].
The results described above show that autophagy contributes to
the prevention of tumorigenesis. Impaired autophagy can contribute
to tumor formation via impaired regulation of cell growth, and/or via
decreased cell death. In addition, it was shown that failure to sustain
metabolism via autophagy results in increased DNA damage. This
chromosomal instability increases tumor progression [137].
In advanced cancers, autophagymayhave the opposite effect on the
tumor development. Autophagy can beneﬁt the progression of the
tumor because it canprovide nutrients during starvation [129,130,138].
In addition, autophagy was recently shown to improve the survival of
p53-deﬁcient cancer cells under starvationorhypoxic conditions [139].
These ﬁndings suggest that autophagy inhibition, rather than stimula-
tion, might be beneﬁcial in treatment of advanced cancer.
6.2. Neurodegeneration
Many age-related neurodegenerative diseases are characterized by
the accumulation of ubiquitin-positive protein aggregates in affected
brain regions. Thesemisfolded, aberrant proteins can disrupt neuronal
function and cause neurodegeneration. As described earlier, autop-
hagy is necessary for the clearance of aggregate-prone proteins that
are toxic especially for post-mitotic cells like neurons [130]. Tissue-
speciﬁc knockout of the autophagy genes in neurons causes a massive
accumulation of ubiquitin-positive protein aggregates and neurode-
generation inmice [93,94], indicating that autophagy is needed for the
constitutive clearance of aggregate-prone proteins. Autophagy was
recently shown to enhance the clearance of Huntingtin, mutant tau,
synphilin 1 andα-synuclein, but not AIMP2 (p38) andmutant desmin
[140]. This study indicates that autophagy is not able to degrade all
protein aggregates. However, the role of autophagy has been
demonstrated in Huntington's disease, caused by mutations in
Huntingtin, and familial Parkinson's disease, caused by mutations in
α-synuclein. Enhanced autophagy in animal models of these diseases
improves clearance of the aggregated proteins and reduces the
symptoms of neurodegeneration [95,141].
ESCRTcomplexes are necessary for the biogenesis of multivesicular
endosomes. As described earlier, multivesicular endosomes are
necessary for the maturation of autophagosomes into degradative
autolysosomes. Mutations in ESCRT III subunits CHMP2B or mSnf7-2
are associated with two neurodegenerative diseases, frontotemporal
dementia and amyotropic lateral sclerosis. Both diseases are char-
acterized by abnormal ubiquitin-positive protein deposits in affected
neurons. Cell lines and fruit ﬂies depleted of CHMP2B or mSnf7-2
show decreased autophagic degradation, increased levels of ubiquitin-
positive aggregates and increased neurodegeneration [27,29].
Alzheimer's disease is characterized by the accumulation of
extracellular amyloid plaques in the brain. These plaques consist of
aggregated β-amyloid (Aβ) peptide. Autophagy was proposed to
contribute to the production of Aβ. Autophagic compartments
containing both amyloid precursor protein and Aβ accumulate in
dystrophic neurons in Alzheimer brain [142,143]. Puriﬁed autophagic
vacuoles contain all necessary constituents for Aβ production [142],
and autophagic compartments were identiﬁed as a major reservoir of
intracellular Aβ in the brain of Alzheimer patients and mouse models.
The primary cause for the increased accumulation of autophagic
compartments in Alzheimer's disease was recently suggested to be
their retarded maturation to autolysosomes [144].
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contributes to the pathogenesis of Alzheimer's disease. Beclin 1 was
shown to be decreased in affected brain regions of patients with
Alzheimer disease early in the disease process [145]. Heterozygous
deletion of Beclin 1 in mice decreased neuronal autophagy and
resulted in neurodegeneration. Transgenic mice expressing human
amyloid precursor protein have been used as a mouse model for this
disease. Genetic reduction of Beclin 1 expression increased intraneur-
onal Aβ accumulation, extracellular Aβ deposition, and neurodegen-
eration [145]. Increasing Beclin 1 levels by lentiviral expression
reduced both intracellular and extracellular amyloid pathology in
these transgenic mice. This study suggests that decreased, not
increased, autophagy promotes Alzheimer's disease progression.
Further, enhancing autophagy by increasing Beclin 1 levels may
have therapeutic potential in this disease.
6.3. Autophagy and lysosomal storage diseases
Niemann–Pick type C is a neurodegenerative lipid storage disorder
characterized by a disruption of sphingolipid and cholesterol trafﬁck-
ing caused by mutations in either of two genes, npc1 and npc2. The
disease produces cognitive impairment, ataxia and death, often in
childhood. Cells deﬁcient in npc genes show increased expression of
Beclin 1 and LC3-II, the autophagosome-speciﬁc form of LC3,
suggesting autophagy is induced [146]. Increased levels of LC3-II
have also been observed in npc-deﬁcient brain tissue [147]. npc-
Deﬁcient cerebellar Purkinje neurons undergo a cell death that was
proposed to depend on autophagy [148], suggesting increased
autophagy may be harmful for neurons in NPC patients.
Most lysosomal storage diseases are caused by deﬁciencies of
lysosomal hydrolases, leading to accumulation of undegraded sub-
strate and other material in the lysosomal compartment. Lysosomal
accumulation of substrates can also affect autophagosome–lysosome
fusion. Autophagosomes accumulate in brain and isolated cell lines of
mouse models of two lysosomal storage diseases associated with
severe neurodegeneration, multiple sulfatase deﬁciency and muco-
polysaccharidosis type IIIA [149]. Signiﬁcantly reduced colocalization
of the lysosomal membrane protein LAMP-1 with the autophagosome
marker LC3 indicates that the fusion of lysosomal compartments with
autophagosomes is impaired. In addition, cell lines isolated from these
mice have decreased ability to degrade aggregate-prone proteins and
show accumulation of polyubiquitinated proteins and non-functional
mitochondria. Thus, neurodegeneration observed in many lysosomal
storage diseases may be at least partially due to impaired autophagic
degradation, which is particularly vital for neurons.
6.4. Autophagy and muscle disorders
Autophagic vacuoles are a frequent feature in numerous muscular
disorders. Such a pathological situation can be observed in patients
suffering from Danon disease, an inherited disease resulting from null
mutations in the lysosomal membrane protein LAMP-2 [83]. LAMP-2
deﬁciency leads to a fatal cardiomyopathy and myopathy sometimes
associated with mental retardation [150]. Accumulation of autophagic
vacuoles in the heart and skeletal muscle are hallmarks of the disease
[84]. Studies in LAMP-2 deﬁcientmice revealed in part similar ﬁndings
[85]. Fifty percent of these mice die at an early postnatal age with
massive accumulation of autophagic vacuoles in several tissues
including liver, pancreas, spleen, kidney, lymph nodes, neutrophilic
leukocytes, skeletal muscle, and heart. Autophagic vacuoles contain-
ing single mitochondria were frequently observed in cardiomyocytes
[151] indicating that mitochondria are a main target for autophagic
degradation in muscle tissues. These cellular alterations lead to a
reduced contractility and an increased size of the heart in LAMP-2
knockout mice. This is in agreement with the ﬁnding that cardiomyo-
pathy is the hallmark in Danon disease patients [83]. Biochemical andelectron microscopy studies reveal that a retarded consumption,
rather than increased formation, of autophagic vacuoles leads to their
accumulation [152]. LAMP-double deﬁcient ﬁbroblasts lack both
LAMP-2 and the structurally related LAMP-1 protein. These cells
show a defect in the ﬁnal maturation steps of late autophagic vacuoles,
involving retarded fusion with lysosomes [33,119]. Interestingly,
recruitment of the small GTPase Rab7 to autophagosomes is retarded
in these cells [32].
Inhibition of lysosomal fusion using hydroxy-chloroquine causes
similar vacuolar alterations and myopathies to Danon disease,
conﬁrming the important role of lysosome–autophagosome fusion
formuscle cell physiology [153]. Impaired autophagosomematuration
may also be related to other types of diseases such as X-linked
myopathy with excessive autophagy, infantile autophagic vacuolar
myopathy, adult-onset autophagic vacuolar myopathy with multi-
organ involvement, and X-linked congenital autophagic vacuolar
myopathy [154]. The molecular defects in these disorders are still
unknown.
Although altered autophagy has been observed in various heart
diseases, including cardiac hypertrophy and heart failure, it remains
unclear whether autophagy plays a beneﬁcial or detrimental role in
these diseases. As mentioned earlier, tissue-speciﬁc deletion of atg5 in
heart causes cardiac hypertrophy and contractile dysfunction [86]. In
addition, increased levels of ubiquitinated proteins and abnormal
mitochondria are found, especially after treatment with pressure
overload or β-adrenergic stress. This suggests that autophagy is
needed in the heart to ensure the availability of sufﬁcient energy
substrates and to control cardiomyocyte size and global cardiac
structure and function.
6.5. Common aspects in autophagy and phagocytosis
As described above, autophagy plays a role in innate immunity
against intracellular pathogens [104,105] by clearing microbes directly
via ingestion into autophagosomes for subsequent degradation in
autolysosomes [108,155]. Similar to the process of intracellular
defense, phagocytosis is an evolutionary conserved mechanism
involved in the removal of extracellular organisms. Interestingly, it
was found that the phagocytic and autophagic pathways are linked.
Toll like receptor (TLR) activation triggers the recruitment of
autophagy proteins LC3, Atg5 and Atg7 to the phagosomal pathway.
Before these events Beclin 1 and class III PI3-kinase activity are found
in phagosomes [156]. These autophagy-speciﬁc proteins are recruited
to the phagosome, while almost no classical autophagosomes are
observed in the cells. Phagosome fusion with lysosomes is then
initiated, leading to acidiﬁcation and killing of the ingested organisms.
Thus, engaging the autophagy pathway via TLR signaling (especially
TLR7 through its binding to single-stranded RNA) enhances phago-
some maturation and destruction of pathogens [157]. This under-
scores the intimate link between autophagy and phagocytosis.
As mentioned earlier, M. tuberculosis is able to survive inside
macrophages by preventing the fusion of phagosomes with lyso-
somes, but induction of autophagy bypasses the maturation defect,
leading to phagolysosome formation and bacterial killing [108].
Autophagy induction induces the localization of Beclin 1 and LC3 to
phagosomes, suggesting the phagosomes are diverted to an autopha-
gosome-like compartment that is then able to fuse with lysosomes.
The association between autophagy and phagocytosis is also
underlined by studies with cells lacking either one or both LAMPs
[33]. As described above, autophagosome–lysosome fusion is
impaired in LAMP-double deﬁcient cells [32]. Whereas macrophages
and ﬁbroblasts from LAMP-1 or LAMP-2 single-deﬁcient mice display
normal fusion of lysosomes with phagosomes, in LAMP-double
knockout ﬁbroblasts phagosomes are unable to recruit late endoso-
mal/lysosomal markers and phagocytosis is arrested prior to the
acquisition of Rab7 [158]. Interestingly, the maturation of Neisseria-
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proteins fail to kill the engulfed pathogens [159]. Thematuration block
caused by LAMP deﬁciency is at least partially due to the inability of
autophagosomes and phagosomes to undergo dynein/dynactin-
mediated centripetal movement along microtubules towards lyso-
somes [158]. Interestingly LAMP-2 single knockout mice show an
impaired phagosomal maturation in neutrophilic leucocytes. The
impairment of this innate immune defense mechanism leads to
periodontitis, which is one of the most widespread infectious diseases
worldwide. The retarded clearance of bacterial pathogens is due to an
inefﬁcient fusion between lysosomes and phagosomes, leading to less
efﬁcient killing of the ingested pathogens [160,161]. Neutrophils of the
LAMP-2 knockout mice also contain an accumulation of autophagic
vacuoles [85,160], which is likely also due to impaired fusion of
autophagosomes with lysosomes.
Taken together these observations indicate that fusion with
lysosomes is required to successfully complete both autophagosome
and phagosome maturation that is necessary for efﬁcient degradation
of the cargo. Further, the results show that the maturation of
autophagosomes and phagosomes share common features, because
both processes are impaired with similar tissue and cell speciﬁcity in
LAMP-2 deﬁcient mice and LAMP-double deﬁcient cell lines.
7. Conclusions
Degradation of cytosolic proteins in lysosomes via autophagy has
turned out to have numerous, partly unexpected, roles in health and
disease. Autophagy has been shown to contribute to innate and
adaptive immunity and longevity, and to the prevention of cancer
and neurodegeneration, just to mention a few of its newly-revealed
functions. Treatments for human diseases that speciﬁcally target
autophagy do not yet exist. It is likely, however, that such
treatments will emerge in the future, once the molecular mechan-
isms of the processes involved in autophagy regulation have been
clariﬁed and suitable inducers and inhibitors for clinical trials have
been identiﬁed.References
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